logo-loader
RNS
Checkit PLC

Checkit PLC - Contract win

RNS Number : 2252A
Checkit PLC
01 February 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

 

1 February 2022

 

Checkit plc

 

("Checkit" or the "Group")

 

Contract win

 

Checkit plc (AIM: CKT) is pleased to announce it has signed a three year contract with Biomat USA, Inc., a subsidiary of Grifols S.A. ("Grifols"). The contract has a minimum total value of £2.8 million spread evenly over the three year period, and will involve providing services to over 300 sites which will see Checkit extend its US footprint within Grifols to initially five of its US subsidiaries.

 

Grifols is a global leader in the production of plasma-derived medicine and transfusion medicines. Headquartered in Spain, it has a worldwide network of over 350 plasma centres, including more than 50 in Europe. With revenues of €5.3bn (of which €3.6bn were generated from US operations during 2020), Grifols employs 24,000 people providing products and services in more than 100 countries worldwide.

 

Of the total contract value, approximately 12% represents the renewal of existing business with Grifols with the remainder representing upsell and new business.

 

The agreement establishes Checkit as Grifols' partner of choice for the provision of intelligent operations technology in the US. In addition, expansion of the Checkit platform to cover Grifols' key countries of operations in Europe is at advanced stages of discussion.

 

Additionally, Grifols plans to build 20 plasma centres in Egypt, with Checkit having recently signed a separate three year contract to provide intelligent operations services to the first ten of these.

 

Checkit CEO Kit Kyte said: "We look forward to the continued growth of our relationship internationally. Our partners at Grifols already appreciate the power of our monitoring services and the future addition of workflow management will give them unprecedented levels of digital control and data-driven insight, as we look for ways to streamline their complex, globally distributed operations. This deal provides further confirmation of the importance of our technology in enabling intelligent operations across deskless workforces."

 

 

Enquiries:

Checkit plc

 

+44 (0)1223 643313

www.checkit.net

 

 

Kit Kyte (Chief Executive Officer)

 

 

Greg Price (Chief Financial Officer)

 

 

 

 

 

Singer Capital Markets (Nominated Adviser & Broker)

 

+44 (0) 20 7496 3000

Shaun Dobson / Harry Gooden / George Tzimas (Investment Banking)

 

 

 

 

About Checkit

 

Checkit is the intelligent operations platform for deskless workforces, enabling operational agility and intelligent decision-making in large multinational and complex national organisations. The solution offers optional plugins for sensor networks and smart building management.

 

The Checkit Connect platform prompts, guides, captures and analyses frontline activities through digital workflows. Real-time data is captured from multiple workplaces. The platform empowers leaders to comprehend and continually improve processes, enhancing innovation, productivity, efficiency, energy usage, waste reduction, customer experience, safety and compliance.

 

Checkit provides intelligent operations tools to the retail, franchise, healthcare, life sciences, facilities management, catering, manufacturing, hospitality and commercial property sectors.

 

Checkit has customers including the UK NHS, bp, Waitrose, Sodexo and Center Parcs. The Checkit platform generates around 11bn data points per year from sensors and digital workflows.

 

Checkit is headquartered in Cambridge, UK, with its operations centre in Fleet, UK, and US office in Florida. The company has over 185 employees.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFSTLLILVIF
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Board Changes

4 weeks ago

Holding(s) in Company

on 09/28/2026

Form 8.5 (EPT/RI)

on 09/28/2026

Interim Results

on 09/28/2026

Termination of FSP

on 09/28/2026

Form 8.5 (EPT/RI)

on 09/25/2026

Form 8.5 (EPT/RI)

on 09/24/2026

4 min read